Zimmer Biomet Holdings Inc. (ZBH)

112.09
NYSE : Health Technology
Prev Close 112.09
Day Low/High 0.00 / 0.00
52 Wk Low/High 104.28 / 133.49
Avg Volume 1.16M
Exchange NYSE
Shares Outstanding 203.27M
Market Cap 22.73B
EPS 9.00
P/E Ratio 13.50
Div & Yield 0.96 (0.86%)

Latest News

The New #246 Most Shorted S&P 500 Component: Zimmer Biomet Holdings

The New #246 Most Shorted S&P 500 Component: Zimmer Biomet Holdings

The most recent short interest data has been released for the 05/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Zimmer Biomet To Present At Goldman Sachs 39th Annual Global Healthcare Conference

Zimmer Biomet To Present At Goldman Sachs 39th Annual Global Healthcare Conference

WARSAW, Ind., June 7, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.

Zimmer Biomet Announces 510(k) Clearance For Zyston® Strut Open Titanium Interbody Spacer System

Represents the Company's first titanium spinal implant manufactured via an additive manufacturing process

Zimmer Biomet Announces Call For Applications For The 2018 Connected Health Innovation Award

The Zimmer Biomet Connected Health Innovation Award Recognizes Innovative Technology-Enabled Solutions Targeting Current and Future Needs in Musculoskeletal Healthcare

Zimmer Biomet Partners With Faith In Practice To Improve Access To Musculoskeletal Care In Guatemala

Partnership reinforces Zimmer Biomet's commitment to delivering charitable and sustainable healthcare solutions to meet the needs of the underserved global population

Zimmer Biomet Announces FDA Clearance Of The Comprehensive® Augmented Baseplate For Shoulder Reconstruction

Zimmer Biomet Announces FDA Clearance Of The Comprehensive® Augmented Baseplate For Shoulder Reconstruction

First Surgical Case Utilizing the Simplified Baseplate That is Designed to Offer Optimal Fixation and Bone Preservation Follows Regulatory Clearance

Zimmer Biomet Joins U.S. Department Of Energy's Better Buildings, Better Plants Program

Zimmer Biomet Joins U.S. Department Of Energy's Better Buildings, Better Plants Program

Participation Includes Efforts to Improve Energy Efficiency and Reduce Carbon Footprint

Zimmer Biomet Exhibits Product And Service Innovations At AAOS 2018

Zimmer Biomet Exhibits Product And Service Innovations At AAOS 2018

Newly FDA-Cleared Persona® Partial Knee System, Persona® Trabecular Metal™ Tibia, Comprehensive® Augmented Baseplate and Sidus® Stem-Free Shoulder Featured Onsite and Highlighted as a Part of Educational Series

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: HP, PNR, ZBH Downgrades: BEN, BXP, CWBC, IDTI, INOV, MOD, NATI, PII, QTS, RMBS, SONA, TROW, UBSI, UTMD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Zimmer Biomet Holdings Achieves #56 Analyst Rank, Surpassing Range Resources

Zimmer Biomet Holdings Achieves #56 Analyst Rank, Surpassing Range Resources

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zimmer Biomet Holdings Inc has taken over the #56 spot from Range Resources Corp , according to ETF Channel. Below is a chart of Zimmer Biomet Holdings Inc versus Range Resources Corp plotting their respective rank within the S&P 500 over time (ZBH plotted in blue; RRC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Zimmer Biomet Announces FDA Clearance Of The Sidus® Stem-Free Shoulder System

Zimmer Biomet Announces FDA Clearance Of The Sidus® Stem-Free Shoulder System

A Clinically-Proven and Effective Bone Preserving Solution for Shoulder Arthroplasty

Stocks That Gain From New Tax Law: Cramer's 'Mad Money' Recap (Wed 12/20/17)

Stocks That Gain From New Tax Law: Cramer's 'Mad Money' Recap (Wed 12/20/17)

Which stocks fit the 'profile'? They benefit from the tax overhaul and are under-loved by Wall Street, says Jim Cramer.

A Drug Giant, a Maker of Artificial Joints and Other Stocks That Look Good Short

MRK, PEGA, FNGN, RGNX and ZBH all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANF, CWCO, DOOR, GCP, OSN, PLT, SJT, TRC Downgrades: FNGN, OPNT, ZBH Initiations: CSTR, DRNA, MPO, MRT Read on to get TheStreet Quant Ratings' detailed report:

Russell 2000 Skips the Party

Number of stocks making new highs keeps climbing.

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

Zimmer Biomet: Cramer's Top Takeaways

Zimmer Biomet: Cramer's Top Takeaways

Jim Cramer says sometimes a company can have a great long-term story, but management fails to deliver.

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.

Zimmer Biomet Stock Jumps After Jana Said to Have Taken Significant Stake

Zimmer Biomet Stock Jumps After Jana Said to Have Taken Significant Stake

While the size of the stake is unclear, Jana's Nirvana Offshore Fund recently received an Early Termination Notice from the FTC, allowing the firm to increase its stake.

TheStreet Quant Rating: B- (Buy)